Melanoma Stage IIIB-IV Clinical Trials
0 recruiting
Showing 1–2 of 2 trials
Recruiting
Phase 2Phase 3
A Trial of LNS8801 With or Without Pembrolizumab in Patients With Refractory Melanoma
Unresectable MelanomaCutaneous MelanomaMelanoma (Skin Cancer)+1 more
Linnaeus Therapeutics, Inc.135 enrolled7 locationsNCT06624644
Recruiting
Phase 2
NeoLIPA: Neoadjuvant LTX-315 in Combination with Pembrolizumab in Resectable Stage III/IV Melanoma
Melanoma Stage IIIB-IV
Oslo University Hospital27 enrolled1 locationNCT06651151